首页> 外文期刊>Biochemical Pharmacology >Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists
【24h】

Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists

机译:非典型趋化因子受体Ackr3 / CXCR7的细胞外二硫桥的突变分析揭示了其趋化因子和内源性非趋化因子激动剂的多种结合和活化模式

获取原文
获取原文并翻译 | 示例
       

摘要

The atypical chemokine receptor ACKR3/CXCR7 plays crucial roles in numerous physiological processes but also in viral infection and cancer. ACKR3 shows strong propensity for activation and, unlike classical chemokine receptors, can respond to chemokines from both the CXC and CC families as well as to the endogenous peptides BAM22 and adrenomedullin. Moreover, despite belonging to the G protein coupled receptor family, its function appears to be mainly dependent on beta-arrestin. ACKR3 has also been shown to continuously cycle between the plasma membrane and the endosomal compartments, suggesting a possible role as a scavenging receptor. So far, the molecular basis accounting for these atypical binding and signalling properties remains elusive. Noteworthy, ACKR3 extracellular domains bear three disulphide bridges. Two of them lie on top of the two main binding subpockets and are conserved among chemokine receptors, and one, specific to ACKR3, forms an intra-N terminus four-residue-loop of so far unknown function. Here, by mutational and functional studies, we examined the impact of the different disulphide bridges for ACKR3 folding, ligand binding and activation. We showed that, in contrast to most classical chemokine receptors, none of the extracellular disulphide bridges was essential for ACKR3 function. However, the disruption of the unique ACKR3 N-terminal loop drastically reduced the binding of CC chemokines whereas it only had a mild impact on CXC chemokine binding. Mutagenesis also uncovered that chemokine and endogenous non-chemokine ligands interact and activate ACKR3 according to distinct binding modes characterized by different transmembrane domain subpocket occupancy and N-terminal loop contribution, with BAM22 mimicking the binding mode of CC chemokine N terminus.
机译:非典型趋化因子受体Ackr3 / CXCR7在众多生理过程中起着至关重要的作用,也在病毒感染和癌症中起着至关重要的作用。 Ackr3显示出强烈的激活倾向,与古典趋化因子受体不同,可以对CXC和CC系列以及内源肽BAM22和肾上腺髓质素响应趋化因子。此外,尽管属于G蛋白偶联受体家族,其功能似乎主要依赖于β-Arcketin。 AckR3还被证明在质膜膜和内体隔室之间连续循环,表明可能是清除受体的可能作用。到目前为止,这些非典型结合和信号性能的分子基础核算仍然难以捉摸。值得注意的是,Ackr3细胞外座有三个二硫桥。其中两个位于两个主要结合子袋的顶部,并且在趋化因子受体中保存,并且特定于AckR3,形成到目前为所未知功能的n个末端四分之一 - 循环。这里,通过突变和功能性研究,我们检查了不同二硫桥对Ackr3折叠,配体结合和活化的影响。我们表明,与大多数常规趋化因子受体相比,没有一个细胞外二硫代曲桥对于AckR3功能至关重要。然而,独特Ackr3 n末端环路的破坏大大降低了CC趋化因子的结合,而它仅对CXC趋化因子结合具有轻微的影响。诱变还揭示了趋化因子和内源性非趋化因子配体根据具有不同跨膜结构域壳占用和N-末端环路的不同结合模式相互作用和活化AckR3,用BAM22模拟CC趋化因子N末端的结合模式。

著录项

  • 来源
    《Biochemical Pharmacology》 |2018年第2018期|共11页
  • 作者单位

    LIH Dept Infect &

    Immun Immuno Pharmacol &

    Interact 29 Rue Henri Koch L-4354 Luxembourg;

    LIH Dept Infect &

    Immun Immuno Pharmacol &

    Interact 29 Rue Henri Koch L-4354 Luxembourg;

    LIH Dept Infect &

    Immun Immuno Pharmacol &

    Interact 29 Rue Henri Koch L-4354 Luxembourg;

    LIH Dept Infect &

    Immun Immuno Pharmacol &

    Interact 29 Rue Henri Koch L-4354 Luxembourg;

    Univ Liege GIGA Mol Biol Dis Lab Mol Pharmacol GIGA B34 11 Ave Hop B-4000 Liege Belgium;

    Vrije Univ Brussel Struct Biol Brussels B-1050 Brussels Belgium;

    LIH Dept Infect &

    Immun Immuno Pharmacol &

    Interact 29 Rue Henri Koch L-4354 Luxembourg;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    Chemokine receptor; CXCR7; ACKR3; CXCR4; BAM22; CXCL12; Adrenomedullin;

    机译:趋化因子受体;CXCR7;ACKR3;CXCR4;BAM22;CXCL12;adrenomedullin;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号